Literature DB >> 3019597

Plasma-free eicosapentaenoic acid/arachidonic acid ratio: a possible new coronary risk factor.

T Kondo, K Ogawa, T Satake, M Kitazawa, K Taki, S Sugiyama, T Ozawa.   

Abstract

Seventy-six effort angina patients who had typical angina on exertion documented by treadmill stress test with evidence of ischemic ST-segment depression and 78 healthy volunteers in urban Japan were investigated in this study. Plasma free fatty acids (FFA) in both groups were determined using high-performance liquid chromatography. The relationships between the total cholesterol, high-density lipoprotein (HDL), triglycerides in plasma, and the genesis of coronary heart disease were also examined. The ratio (0.08 +/- 0.08) of eicosapentaenoic acid (EPA)/arachidonic acid (AA) in plasma FFA was significantly lower in effort angina patients than that (0.15 +/- 0.12) in healthy volunteers. The lower ratio was due to significantly lower levels of EPA in the patients than in normals. In 42% of angina patients, the ratio is below 0.03. In all age subgroups except the age 30-39 subgroup, the ratio of EPA/AA was significantly lower in patients than in normals, when divided into four subgroups by using a 10-year age interval. Though the total cholesterol and triglycerides were not significantly different between the two groups, HDL was significantly lower and total cholesterol/HDL ratio was significantly higher in effort angina patients than in healthy volunteers. However, there was no correlation between EPA/AA ratio and HDL in individuals in either group. From these results, it could be concluded that lower EPA/AA ratio is a new coronary risk indicator other than HDL.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019597     DOI: 10.1002/clc.4960090905

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  8 in total

1.  Ratios of substrates and inhibitors of prostaglandin synthesis in blood plasma of patients with heart ischemia.

Authors:  A T Mevkh; A K Yuskovich; V S Duzhenko; E D Lee; A L Vertkin; I A Pishkina
Journal:  Appl Biochem Biotechnol       Date:  1996 Oct-Nov       Impact factor: 2.926

2.  Association of serum levels of arachidonic acid and eicosapentaenoic acid with prevalence of major adverse cardiac events after acute myocardial infarction.

Authors:  Masayuki Ueeda; Takenori Doumei; Yoichi Takaya; Nobuhiko Ohnishi; Atsushi Takaishi; Satoshi Hirohata; Toru Miyoshi; Ryoko Shinohata; Shinichi Usui; Shozo Kusachi
Journal:  Heart Vessels       Date:  2010-10-21       Impact factor: 2.037

3.  Albumin-bound docosahexaenoic acid and collagen-induced human platelet reactivity.

Authors:  D C Gaudette; B J Holub
Journal:  Lipids       Date:  1990-03       Impact factor: 1.880

Review 4.  Dietary fish oils containing eicosapentaenoic acid and the prevention of atherosclerosis and thrombosis.

Authors:  B J Holub
Journal:  CMAJ       Date:  1988-09-01       Impact factor: 8.262

5.  Effect of exercise on FA profiles in n-3 FA-supplemented and -nonsupplemented premenopausal women.

Authors:  Julie A Conquer; Heather Roelfsema; Julie Zecevic; Terry E Graham; Bruce J Holub
Journal:  Lipids       Date:  2002-10       Impact factor: 1.880

6.  Effect of purified eicosapentaenoic acid on red cell distribution width in patients with ischemic heart disease.

Authors:  Masao Takahashi; Masahiro Myojo; Aya Watanabe; Arihiro Kiyosue; Koichi Kimura; Jiro Ando; Yasunobu Hirata; Issei Komuro
Journal:  Heart Vessels       Date:  2014-05-31       Impact factor: 2.037

7.  Coronary Artery Disease Severity and Cardiovascular Biomarkers in Patients with Peripheral Artery Disease.

Authors:  Hiroyuki Hikita; Takatoshi Shigeta; Shigeki Kimura; Atsushi Takahashi; Mitsuaki Isobe
Journal:  Int J Angiol       Date:  2015-06-26

8.  Plasma lipids and fatty acids in urbanized Bushmen, Hereros and Kavangos of southern Africa (Namibia).

Authors:  H Y Tichelaar; A J Benadé; S J O'Keefe; P L Jooste; S A Swanevelder; E Van Staden
Journal:  Lipids       Date:  1992-09       Impact factor: 1.880

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.